Journal
JOURNAL OF NEUROCHEMISTRY
Volume 106, Issue 1, Pages 205-215Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1471-4159.2008.05358.x
Keywords
brain iron; dopamine; dopamine transporter; iron deficiency; L-DOPA; microdialysis; norepinephrine
Categories
Funding
- NIA NIH HHS [AG021190] Funding Source: Medline
- NINDS NIH HHS [NS35088] Funding Source: Medline
Ask authors/readers for more resources
Iron deficiency (ID) disrupts brain dopamine (DA) and norepinephrine (NE) metabolism including functioning of monoamine transporters and receptors. We employed caudate microdialysis and no net flux (NNF) in post-weaning rats to determine if ID decreased the extraction fraction (E(d)). Five micromolar quinpirole, a dopamine D(2) receptor agonist, resulted in 80% decrease in extracellular DA and 45% higher E(d) in control animals. The D(2) agonist had no effect on E(d) in ID animals despite a reduction in basal DA. DAT mRNA levels were reduced by 58% with ID, while DAT protein in ventral midbrain and caudate and membrane associated DAT were also reduced by ID. Carbidopa/L-DOPA was administered to determine if elevated extracellular DA in ID was due to increased release. The DA response to L-DOPA in ID rats was 50% smaller and delayed, whereas the NE response was threefold higher. The caudate concentration of NE was also elevated in ID. Elevated dopamine-beta-hydroxylase activity in ID provides a tentative explanation for the increased NE response to L-DOPA. These experiments provide new evidence that ID results in altered synthesis and functioning of DAT and perhaps suggests some compensatory changes in NE metabolism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available